Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20101
20132
20142
20151
20171
20181
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Active, not recruiting2
Not yet recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Novartis Pharmaceuticals2
Bayer1
Boston Scientific Corporation1
CID S.p.A.1
Chinese Academy of Medical Sciences, Fuwai Hospital1
Eighth Affiliated Hospital, Sun Yat-sen University1
Janssen Research & Development, LLC1
Kunming Medical University1
Medtronic Vascular1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease15
Myocardial Infarction4
Stroke3
Angina Pectoris2
Cardiovascular Diseases2
Myocardial Ischemia2
Acute Coronary Syndrome1
Angina, Stable1
Angina, Unstable1
Arteriosclerosis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.